Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019)

Acro Biomedical has reported Deferred Taxes over the past 2 years, most recently at -$19941.0 for Q3 2019.

  • Quarterly results put Deferred Taxes at -$19941.0 for Q3 2019, changed N/A from a year ago — trailing twelve months through Sep 2020 was -$47888.0 (down 71.35% YoY), and the annual figure for FY2019 was -$19941.0, changed.
  • Deferred Taxes for Q3 2019 was -$19941.0 at Acro Biomedical, up from -$73071.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for ACBM hit a ceiling of $45124.0 in Q1 2019 and a floor of -$73071.0 in Q2 2019.